F-1: Wearable Devices Files for Resale of 1.67M Shares

Wearable Devices Ltd. filed an F-1 registration statement for the resale of up to 1,670,000 ordinary shares by a selling shareholder, potentially generating $8.02 million for the company from warrant exercises.

Summary

• Wearable Devices Ltd. filed an F-1 registration statement for the resale of up to 1,670,000 ordinary shares by Armistice Capital, LLC, the selling shareholder.
• These shares are issuable upon the exercise of 1,000,000 September 12 Warrants at an exercise price of $4.00 per share and 670,000 September 15 Warrants at an exercise price of $6.00 per share.
• The company will not receive proceeds from the sale of shares by the selling shareholder but expects to receive up to approximately $8.02 million from the exercise of these warrants, which will be used for working capital and general corporate purposes.
• The company develops non-invasive neural input interfaces, including the Mudra Band for Apple Watch (shipping since December 2023) and the universal Mudra Link wristband (pre-orders in September 2024, shipping Q1 2025).
• Revenues were $522 thousand in 2024 and $82 thousand in 2023, with comprehensive and net losses of $7.9 million and $7.8 million, respectively.
• For the six months ended June 30, 2025, revenues were $294 thousand, and comprehensive and net loss was $3.7 million, compared to revenues of $394 thousand and a loss of $4.2 million for the same period in 2024.
• Over 100 companies, including 30 multinational technology companies, have purchased the Mudra Development Kit, but no licensing agreements have been signed as of September 18, 2025.
• The company's financial statements for the six months ended June 30, 2025, included an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern.

Sentiment

Score: 3

Explanation: The company faces significant financial challenges, including an explicit 'going concern' doubt and declining revenues in the most recent period. While the potential for warrant exercise proceeds is positive for liquidity, the substantial dilution risk and lack of B2B licensing agreements are major concerns. The long-term vision is ambitious but currently lacks concrete commercialization success in its B2B segment.

Positives

• The company has the potential to receive up to $8.02 million in cash from the exercise of the September 12 and September 15 Warrants, which will be used for working capital and general corporate purposes.
• Successful launch and commencement of shipments for B2C products, the Mudra Band (since December 2023) and Mudra Link (Q1 2025).
• Over 100 companies, including 30 multinational technology companies, have purchased the Mudra Development Kit, indicating interest in the company's B2B technology.
• The company is expanding its brand to include neurotech, brain-computer interface sensors, Industry 4.0, digital health, and sport analytics, broadening its market potential.
• The company's vision to establish its technology as the standard input interface for the Metaverse positions it in a high-growth, innovative sector.

Negatives

• Shareholders may experience significant dilution as a result of potential future financings and the exercise of the 1,670,000 warrants, which represent approximately 29.6% of the company's issued and outstanding Ordinary Shares prior to the offering.
• The company has a history of significant comprehensive and net losses, reporting $7.9 million in 2024, $7.8 million in 2023, and $3.7 million for the first half of 2025.
• Revenues for the six months ended June 30, 2025 ($294 thousand), decreased compared to the same period in 2024 ($394 thousand).
• An explanatory paragraph in the financial statements for the six months ended June 30, 2025, highlights substantial doubt about the company's ability to continue as a going concern.
• Despite engaging with over 100 companies, no licensing agreements have been signed with B2B customers as of September 18, 2025, which is concerning given the estimated 3-5 year period for such agreements.
• The market price of the company's Ordinary Shares could decline due to sales by the selling shareholder or future issuances.
• The company does not anticipate paying any cash dividends on its Ordinary Shares in the foreseeable future, making capital appreciation the sole source of gain for shareholders.

Risks

• Shareholders may experience significant dilution from potential future financings, including the exercise of the September 12 and September 15 Warrants (up to 1,670,000 Ordinary Shares, approximately 29.6% of outstanding shares prior to the offering).
• Future issuances or sales of Ordinary Shares or other equity securities could cause the market price to decline and impair the company's ability to raise capital.
• The market price of Ordinary Shares could decline due to sales, or announcements of proposed sales, of a large number of Ordinary Shares, including by large shareholders.
• The company's amended and restated articles of association authorize the board to issue additional Ordinary Shares or convertible securities without shareholder approval, potentially leading to substantial dilution.
• An active trading market for Ordinary Shares may not be sustained, impairing investors' ability to sell shares and the company's ability to raise capital.
• Share price may be subject to substantial volatility, and shareholders may lose all or a substantial part of their investment due to limited public float and historically low/sporadic trading volume.
• The company does not anticipate paying cash dividends, making capital appreciation the sole source of gain.
• Resales of Ordinary Shares in the public market by current shareholders may depress the market price.
• The financial statements for the six months ended June 30, 2025, contained an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern, which could prevent new financing.
• Uncertainty regarding Surface Nerve Conductance (SNC) becoming the industry standard input method for wearable computing and consumer electronics.
• The company's ability to maintain and expand its existing customer base and compatibility of devices with a broad range of mobile devices and operating systems.
• The company's ability to maintain its business models and correctly predict market growth.
• The company's ability to remediate material weaknesses in its internal control over financial reporting.
• The company's ability to retain its founders.
• The company's ability to maintain, protect, and enhance its intellectual property.
• The impact of competition and new technologies.
• General market, political, and economic conditions in the countries in which the company operates, including tariffs, trade restrictions, geopolitical shifts, and conflicts in Israel and other parts of the Middle East.
• The company's ability to comply with Nasdaq listing requirements.
• Litigation.
• Enforceability of U.S. civil liabilities in Israel may be difficult due to jurisdictional and legal procedural differences.

Future Outlook

The company's vision is to establish its technology as the standard input interface for the Metaverse, transforming interaction with digital devices to be natural and intuitive. It believes neural-based interfaces will become ubiquitous for wearable computing and digital devices. The company aims to commercialize Mudra technology by licensing it for integration into B2B products and services, estimating a three-to-five-year period for licensing agreements.

Management Comments

• "Our company's vision is to create a world in which the user's hand becomes a universal input device for touchlessly interacting with technology."
• "We believe that our technology is setting the standard input interface for the Metaverse."
• "We intend to transform interaction and control of digital devices to be as natural and intuitive as real-life experiences."
• "We imagine a future in which humans can share skills, thoughts, emotions, and movements with each other and with computers, using wearable interfaces and devices."
• "We believe that neural-based interfaces will become as ubiquitous to interact with wearable computing and digital devices in the near future as the touchscreen is a universal input method for smartphones."

Industry Context

The company operates in the rapidly evolving wearable technology, neurotech, and brain-computer interface (BCI) sectors. Its focus on gesture control and neural input interfaces positions it at the forefront of human-computer interaction, particularly relevant for the emerging Metaverse, AR/VR, and Industry 4.0 applications. The market for such intuitive control methods is growing as digital devices become more integrated into daily life and new immersive experiences demand more natural interaction. The company's B2B strategy, targeting multinational technology companies, aligns with the trend of integrating advanced input methods into a wide range of consumer electronics and industrial applications.

Comparison to Industry Standards

• The filing does not provide specific comparisons to comparable companies, projects, or results within the industry. It states the company's belief that its technology is 'setting the standard input interface for the Metaverse' and that 'neural-based interfaces will become as ubiquitous...as the touchscreen is a universal input method for smartphones,' but these are forward-looking statements without specific benchmarks or competitive analysis.

Corporate Governance

Legal Proceedings

• No specific legal proceedings are detailed in the filing, but 'litigation' is listed as a general risk factor that could cause actual performance or results to differ materially from forward-looking statements.

Related Party Transactions

• The filing states that, to the company's knowledge, the Selling Shareholder (Armistice Capital, LLC) does not have, and has not had within the past three years, any position, office or other material relationship with the company or its affiliates, other than its ownership of Ordinary Shares, Warrants, and pre-funded warrants, and transactions relating to their issuances or exercises.

Stakeholder Impact

• Shareholders face significant dilution risk from current and future offerings, potential decline in share price, and no anticipated cash dividends, making capital appreciation the sole source of return.
• Employees, directors, and consultants benefit from existing share option plans and restricted share units (RSUs), aligning their interests with company performance.
• Creditors may view the 'going concern' doubt as a heightened risk, potentially impacting the company's ability to secure future financing on favorable terms.
• B2B customers continue to engage with the Mudra Development Kit, indicating ongoing interest in the technology, but the lack of signed licensing agreements suggests a prolonged sales cycle.
• B2C customers benefit from the availability and ongoing shipment of the Mudra Band and Mudra Link products, expanding access to the company's gesture control technology.

Next Steps

• The Selling Shareholder may sell the 1,670,000 Ordinary Shares from time to time after the Registration Statement becomes effective.
• The company intends to use proceeds from warrant exercises for working capital and general corporate purposes.
• The company will continue efforts to commercialize Mudra technology by licensing it for integration in B2B products and services.
• Shareholder approval is required for the issuance of 3,322,000 Ordinary Shares issuable upon the exercise of warrants agreed to be issued under a warrant inducement agreement entered into August 2025.

Key Dates

Recommendation

The company faces severe financial distress, evidenced by an explicit 'going concern' doubt from auditors and declining revenues in the most recent period. While the potential $8.02 million from warrant exercises offers a temporary liquidity boost, it comes with substantial dilution (29.6% of pre-offering shares) and does not address the fundamental lack of profitability or significant B2B licensing revenue. The current share price of $5.55 is above the $4.00 exercise price of the September 12 Warrants, but below the $6.00 exercise price of the September 15 Warrants, indicating mixed market sentiment around these recent capital raises. The long-term commercialization strategy for B2B remains unproven with no signed licensing agreements despite years of engagement. Given the high risk, significant dilution, and fundamental financial instability, a seasoned investor would likely recommend selling to avoid further potential losses.

Keywords

Wearable Devices Ltd., Neural Input Interface, Mudra Band, Mudra Link, Gesture Control, SEC Filing, F-1 Registration, Warrants, Private Placement, Dilution, Nasdaq Capital Market, WLDS, Neurotech, Brain-Computer Interface, Industry 4.0, Digital Health, Sport Analytics, Surface Nerve Conductance (SNC), Augmented Reality (AR), Virtual Reality (VR), Capital Raise, Risk Factors, Financial Reporting